Open AccessDOAJ SealDOAJCrossrefOpenAlex
ESMO Open
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Elsevier
- Subjects
- Advanced Breast Cancer Therapies · Breast Cancer Treatment Studies · cancer · Cancer Genomics and Diagnostics · Cancer Immunotherapy and Biomarkers · Cancer Treatment and Pharmacology · HER2/EGFR in Cancer Research · Lung Cancer Research Studies · Lung Cancer Treatments and Mutations · Neoplasms. Tumors. Oncology. Including cancer and carcinogens · oncology · RC254-282
- Country
- GB
- Languages
- EN
- ISSN
- 2059-7029
- E-ISSN
- 2059-7029
- ISSN-L
- 2059-7029
- Open access
- Yes
- OA since
- 2016
- Publication years
- 1972–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Medicine
- Primary Subfield
- Oncology
- Domain
- Health Sciences
- Confidence
- High
- Publications classified
- 3,044
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 3,660 EUR
- OPENALEX · 2026
- 3,130 GBP
- OPENALEX · 2026
- 484,960 JPY
- OPENALEX · 2026
- 3,910 USD
- DOAJ · 2026
- 4,310 USD
